These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36791594)

  • 1. Efficacy of blonanserin transdermal patch on terminal delirium in patients with respiratory diseases.
    Ando K; Suzuki A; Yoshida H
    Respir Investig; 2023 Mar; 61(2):240-246. PubMed ID: 36791594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible Effect of Blonanserin Transdermal Patch on Antiemetic Control in Patients With Terminal Cancer with Refractory Nausea.
    Ando K; Suzuki A; Yoshida H
    J Palliat Med; 2023 Sep; 26(9):1247-1251. PubMed ID: 37126949
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful Management of Terminal Delirium With Transdermal Blonanserin Patch in a Terminally Ill Cancer Patient.
    Nishiofuku H; Mori M; Yokomichi N; Sakuma Y; Sugiyama K; Takashina Y; Miyagi A; Ishizuka M; Imai K; Morita T
    J Palliat Med; 2024 Feb; ():. PubMed ID: 38335445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Switching from blonanserin oral tablets/powders to transdermal patches alleviates extrapyramidal symptoms in patients with schizophrenia: A 52-week open-label study.
    Ohi K; Takai K; Kuramitsu A; Sugiyama S; Shioiri T
    Prog Neuropsychopharmacol Biol Psychiatry; 2022 Mar; 113():110470. PubMed ID: 34740708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe behavioral and psychological symptoms of dementia successfully treated at home with a blonanserin transdermal patch: A case report.
    Yamaguchi J; Sadahiro R; Hirayama T; Wada S; Nakahara R; Matsuoka H
    Neuropsychopharmacol Rep; 2024 Jun; 44(2):474-478. PubMed ID: 38558544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Striatal Dopamine D2 Receptor Occupancy Induced by Daily Application of Blonanserin Transdermal Patches: Phase II Study in Japanese Patients With Schizophrenia.
    Nishibe H; Tateno A; Sakayori T; Yamamoto M; Kim W; Kakuyama H; Okubo Y
    Int J Neuropsychopharmacol; 2021 Feb; 24(2):108-117. PubMed ID: 32936897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of blonanserin transdermal patch in patients with schizophrenia: A 6-week randomized, double-blind, placebo-controlled, multicenter study.
    Iwata N; Ishigooka J; Kim WH; Yoon BH; Lin SK; Sulaiman AH; Cosca R; Wang L; Suchkov Y; Agarkov A; Watabe K; Matsui T; Sato T; Inoue Y; Higuchi T; Correll CU; Kane JM
    Schizophr Res; 2020 Jan; 215():408-415. PubMed ID: 31471246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceptability of transdermal antipsychotic patches by patients who refuse oral medication and their effectiveness in preventing recurrence of delirium: a retrospective observational study.
    Hatta K; Usui C; Nakamura H
    Int Clin Psychopharmacol; 2023 Jan; 38(1):23-27. PubMed ID: 35980004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of Corresponding Dose of Transdermal Blonanserin to Oral Dose Based on Dopamine D2 Receptor Occupancy: Unique Characteristics of Blonanserin Transdermal Patch.
    Tomita Y; Takagaki T; Kitamura A; Wada E; Nishibe H; Tateno A; Okubo Y
    J Clin Psychopharmacol; 2022 May-Jun 01; 42(3):260-269. PubMed ID: 35384896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic Evaluation of Blonanserin Transdermal Patch: Population Analysis and Simulation of Plasma Concentration and Dopamine D
    Kitamura A; Takagaki T; Nemoto D; Tomita Y; Nishibe H; Kakuyama H
    J Clin Pharmacol; 2021 Aug; 61(8):1069-1080. PubMed ID: 33599975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Switching from blonanserin tablets to blonanserin transdermal patches improves tardive dyskinesia: A case report.
    Sakai S; Morimoto Y; Matsuzaka Y; Nakano T; Kanegae S; Imamura A; Ozawa H
    Neuropsychopharmacol Rep; 2021 Sep; 41(3):440-443. PubMed ID: 34357702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal Delivery of Antipsychotics: Rationale and Current Status.
    Abruzzo A; Cerchiara T; Luppi B; Bigucci F
    CNS Drugs; 2019 Sep; 33(9):849-865. PubMed ID: 31493244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of schizophrenia with relapsed catatonia successfully treated with blonanserin transdermal patch.
    Hagikura M; Inada T
    Neuropsychopharmacol Rep; 2023 Mar; 43(1):150-153. PubMed ID: 36651841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy and safety of blonanserin compared with haloperidol in acute-phase schizophrenia: a randomized, double-blind, placebo-controlled, multicentre study.
    Garcia E; Robert M; Peris F; Nakamura H; Sato N; Terazawa Y
    CNS Drugs; 2009; 23(7):615-25. PubMed ID: 19552488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blonanserin in the treatment of delirium.
    Kato K; Yamada K; Maehara M; Akama F; Kimoto K; Saito M; Yano H; Ichimura A; Matsumoto H
    Psychiatry Clin Neurosci; 2011 Jun; 65(4):389-91. PubMed ID: 21569175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current practice of pharmacological treatment for hyperactive delirium in terminally ill cancer patients: results of a nationwide survey of Japanese palliative care physicians and liaison psychiatrists.
    Matsuda Y; Morita T; Oya K; Tagami K; Naito AS; Kashiwagi H; Otani H
    Jpn J Clin Oncol; 2022 Aug; 52(8):905-910. PubMed ID: 35595535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzodiazepines for treatment of patients with delirium excluding those who are cared for in an intensive care unit.
    Li Y; Ma J; Jin Y; Li N; Zheng R; Mu W; Wang J; Si JH; Chen J; Shang HC
    Cochrane Database Syst Rev; 2020 Feb; 2(2):CD012670. PubMed ID: 32108325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal nicotine and haloperidol in Tourette's disorder: a double-blind placebo-controlled study.
    Silver AA; Shytle RD; Philipp MK; Wilkinson BJ; McConville B; Sanberg PR
    J Clin Psychiatry; 2001 Sep; 62(9):707-14. PubMed ID: 11681767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Oral Risperidone, Haloperidol, or Placebo for Symptoms of Delirium Among Patients in Palliative Care: A Randomized Clinical Trial.
    Agar MR; Lawlor PG; Quinn S; Draper B; Caplan GA; Rowett D; Sanderson C; Hardy J; Le B; Eckermann S; McCaffrey N; Devilee L; Fazekas B; Hill M; Currow DC
    JAMA Intern Med; 2017 Jan; 177(1):34-42. PubMed ID: 27918778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug therapy for delirium in terminally ill adults.
    Finucane AM; Jones L; Leurent B; Sampson EL; Stone P; Tookman A; Candy B
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD004770. PubMed ID: 31960954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.